triazoles has been researched along with zolpidem in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (14.29) | 18.2507 |
| 2000's | 14 (33.33) | 29.6817 |
| 2010's | 16 (38.10) | 24.3611 |
| 2020's | 6 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Kapur, J; Macdonald, RL | 2 |
| Korpi, ER; Matecka, D; Sarviharju, M; Toropainen, M; Wong, G | 1 |
| Greenfield, LJ; Macdonald, RL; Neelands, TR; Turner, RS; Zhang, J | 1 |
| Kapur, J; Macdonald, RL; Tietz, EI | 1 |
| Macdonald, RL; Neelands, TR; Zhang, J | 1 |
| Dillon, GH; Huang, RQ | 1 |
| Bacci, A; Huguenard, JR; Prince, DA; Rudolph, U | 1 |
| DuBois, DW; Frye, GD; Hsiao, SH; Miranda, RC | 1 |
| Kiss, A; Mikkelsen, JD; Mirza, N; Søderman, A | 1 |
| Mathiasen, L; Mirza, NR | 1 |
| Kapur, J; Mtchedlishvili, Z | 1 |
| Mathiasen, LS; Mirza, NR; Rodgers, RJ | 2 |
| Laine, K; Leino, K; Neuvonen, PJ; Olkkola, KT; Saari, TI; Valtonen, M | 1 |
| Groenink, L; Olivier, B; Oosting, R; Toth, M; Van Bogaert, M; van Oorschot, R | 1 |
| Erdi, P; Hajós, M; Hoffmann, WE; Kiss, T; Orbán, G; Ujfalussy, B | 1 |
| Ator, NA; Kohut, SJ | 1 |
| Bundzikova, J; Hansen, HH; Kiss, A; Larsen, MH; Mikkelsen, JD | 1 |
| Allen, MS; Brian Nofsinger, J; Hopkins, SC; Koch, P; Varney, MA | 1 |
| Atack, JR; Cook, JM; Dawson, GR; Licata, SC; Platt, DM; Rowlett, JK; Rüedi-Bettschen, D; Van Linn, ML | 1 |
| Campbell, U; Hanania, T; Hopkins, SC; Min, W; Olivier, B; Paterson, N; Schreiber, R; Vinkers, CH | 1 |
| Cook, JM; Groenink, L; Hansen, HH; Mirza, NR; Nielsen, EØ; Olivier, B; van Oorschot, R; Vinkers, CH | 1 |
| Binns, J; Bowlby, MR; Brunner, J; Cannon, CE; Coleman, PJ; Eddins, DM; Fox, SV; Garson, SL; Gotter, AL; Hodgson, R; Kuduk, SD; Mcdonald, TP; Renger, JJ; Savitz, AT; Stevens, J; Tannenbaum, PL; Tye, SJ; Uslaner, JM; Wang, X; Winrow, CJ; Yao, L | 1 |
| Ator, NA; Biawat, P; Clayton, T; Cook, JM; Rallapalli, SK; Soto, PL; Weed, MR | 1 |
| Bowlby, MR; Brunner, JI; Coleman, PJ; Fox, SV; Garson, SL; Gotter, AL; Hargreaves, R; Hodgson, R; Kuduk, SD; McDonald, TP; Renger, JJ; Savitz, AT; Tannenbaum, PL; Tye, SJ; Uslaner, JM; Winrow, CJ; Yao, L | 1 |
| Catterall, WA; Han, S; Jones, CJ; Scheuer, T; Tai, C | 1 |
| Herring, WJ; Lines, C; Ma, J; Roth, T; Snyder, E; Svetnik, V | 1 |
| Ito, W; Kanbayashi, T; Nishino, S; Satake, M; Shimizu, K; Shimizu, T; Shioya, T; Uemura, SI; Wakasa, M | 1 |
| Bondiskey, P; Cha, JH; Faulknor, J; Kennedy, WP; Levy-Cooperman, N; Lewis, NM; Li, X; Liu, W; McCrea, JB; Panebianco, DL; Schoedel, KA; Sellers, EM; Sun, H; Troyer, MD; Wagner, JA | 1 |
| Drexel, M; Gargano, C; Ma, J; Mayleben, D; Stoch, SA; Struyk, A; Svetnik, V | 1 |
| Hibino, H; Inoue, Y; Matsumoto, H; Mikami, A; Mikami, K; Suzuki, H | 1 |
| Herring, WJ; Lines, C; Roth, T; Scammell, TE; Snyder, ES; Svetnik, V; Tao, P | 1 |
| Nakao, M; Nishimura, S | 1 |
| Cho, M; Honda, T; Kabashima, K; Komori, T; Otsuka, A | 1 |
| Cardoso, R; Farah, B; Goodarzi, Z; Harricharan, S; Leech, J; Morin, CM; Morra, D; Nincic, V; Rios, P; Straus, SE; Tricco, AC | 1 |
| Dauvilliers, Y; Fietze, I; Hedner, J; Mayleben, D; Pain, S; Seboek Kinter, D; Zammit, G | 1 |
| Earl, DC; Van Tyle, KM | 1 |
| Atkins, N; Citrome, L; Frech, F; Juday, T | 1 |
| Dingemanse, J; Kelsh, D; Schoedel, KA; Ufer, M | 1 |
| Allocca, G; Chu, J; Cornthwaite-Duncan, L; Daykin, H; Hoyer, D; Jacobson, LH; Keenan, RJ | 1 |
| Han, G; Imanishi, A; Kanbayashi, T; Nishino, S; Park, I; Satake, M; Shioya, T; Terui, Y; Uemura, SI | 1 |
3 review(s) available for triazoles and zolpidem
| Article | Year |
|---|---|
Pharmacological properties of recombinant and hippocampal dentate granule cell GABAA receptors.
Topics: Animals; Anticonvulsants; Dentate Gyrus; Electric Conductivity; Electrophysiology; GABA-A Receptor Antagonists; Humans; Pyridines; Receptors, GABA-A; Recombinant Proteins; Triazoles; Zinc; Zolpidem | 1999 |
Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews.
Topics: Antidepressive Agents; Antipsychotic Agents; Azepines; Benzodiazepines; Cognitive Behavioral Therapy; Comparative Effectiveness Research; Humans; Hypnotics and Sedatives; Melatonin; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Systematic Reviews as Topic; Triazoles; Zolpidem | 2019 |
New pharmacologic agents for insomnia and hypersomnia.
Topics: Azepines; Carbamates; Dementia; Disorders of Excessive Somnolence; GABA-A Receptor Agonists; Humans; Orexin Receptor Antagonists; Phenylalanine; Piperidines; Pyridines; Pyrimidines; Sleep Aids, Pharmaceutical; Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders; Trazodone; Triazoles; Zolpidem | 2020 |
9 trial(s) available for triazoles and zolpidem
| Article | Year |
|---|---|
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects.
Topics: Adult; Antifungal Agents; Cross-Over Studies; Drug Interactions; Humans; Hypnotics and Sedatives; Male; Pyridines; Pyrimidines; Triazoles; Voriconazole; Zolpidem | 2007 |
Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects.
Topics: Adult; Aged; Azepines; Cross-Over Studies; Double-Blind Method; Electroencephalography; Female; Healthy Volunteers; Humans; Isoxazoles; Male; Middle Aged; Orexin Receptor Antagonists; Polysomnography; Pyridines; Sleep; Sleep Initiation and Maintenance Disorders; Triazoles; Young Adult; Zolpidem | 2014 |
Residual effects of zolpidem, triazolam, rilmazafone and placebo in healthy elderly subjects: a randomized double-blind study.
Topics: Aged; Cross-Over Studies; Double-Blind Method; Female; Healthy Volunteers; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychomotor Performance; Pyridines; Triazolam; Triazoles; Zolpidem | 2015 |
Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study.
Topics: Adult; Azepines; Cross-Over Studies; Double-Blind Method; Euphoria; Female; Hallucinations; Humans; Hypnotics and Sedatives; Illicit Drugs; Male; Middle Aged; Orexin Receptor Antagonists; Prescription Drug Misuse; Pyridines; Triazoles; Zolpidem | 2016 |
Insight Into Reduction of Wakefulness by Suvorexant in Patients With Insomnia: Analysis of Wake Bouts.
Topics: Aged; Azepines; Data Collection; Double-Blind Method; Female; Healthy Volunteers; Humans; Male; Orexin Receptor Antagonists; Placebos; Polysomnography; Problem Solving; Self Report; Sleep; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Triazoles; Wakefulness; Zolpidem | 2018 |
Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder.
Topics: Adult; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Imidazoles; Middle Aged; Orexin Receptor Antagonists; Pyrrolidines; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Zolpidem | 2020 |
Lemborexant for the Treatment of Insomnia: Direct and Indirect Comparisons With Other Hypnotics Using Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed.
Topics: Acetamides; Adolescent; Adult; Azepines; Benzodiazepines; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Orexin Receptor Antagonists; Pyridines; Pyrimidines; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Young Adult; Zolpidem | 2021 |
Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem.
Topics: Azepines; Cross-Over Studies; Double-Blind Method; Drug Users; Humans; Hypnotics and Sedatives; Imidazoles; Orexin Receptor Antagonists; Pyrrolidines; Triazoles; Zolpidem | 2022 |
Residual effects of low dose of suvorexant, zolpidem, and ramelteon in healthy elderly subjects: A randomized double-blind study.
Topics: Aged; Azepines; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Indenes; Male; Orexins; Triazoles; Zolpidem | 2022 |
30 other study(ies) available for triazoles and zolpidem
| Article | Year |
|---|---|
Pharmacological properties of gamma-aminobutyric acidA receptors from acutely dissociated rat dentate granule cells.
Topics: Allosteric Regulation; Animals; Anticonvulsants; Carbolines; Chlorides; Convulsants; Dentate Gyrus; Diazepam; Dose-Response Relationship, Drug; Female; gamma-Aminobutyric Acid; Hypnotics and Sedatives; In Vitro Techniques; Male; Membrane Potentials; Neurons; Patch-Clamp Techniques; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Triazoles; Zinc Compounds; Zolpidem | 1996 |
Pharmacologic actions of subtype-selective and novel GABAergic ligands in rat lines with differential sensitivity to ethanol.
Topics: Animals; Autoradiography; Binding, Competitive; Diazepam; Dose-Response Relationship, Drug; Ethanol; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Male; Motor Activity; Pyridines; Rats; Triazoles; Zolpidem | 1996 |
GABAA receptor pharmacology and subtype mRNA expression in human neuronal NT2-N cells.
Topics: Anticonvulsants; Bicuculline; Carbolines; Convulsants; Diazepam; Diuretics; DNA Primers; Furosemide; GABA Modulators; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Lanthanum; Neurons; Patch-Clamp Techniques; Pentobarbital; Phenobarbital; Picrotoxin; Polymerase Chain Reaction; Pregnanediones; Pregnenolone; Pyridines; Receptors, GABA-A; RNA, Messenger; Teratocarcinoma; Triazoles; Tumor Cells, Cultured; Zinc; Zolpidem | 1998 |
Functional GABAA receptor heterogeneity of acutely dissociated hippocampal CA1 pyramidal cells.
Topics: Allosteric Regulation; Animals; Anticonvulsants; Carbolines; Convulsants; Diazepam; Dose-Response Relationship, Drug; GABA Modulators; gamma-Aminobutyric Acid; Hippocampus; Hypnotics and Sedatives; Membrane Potentials; Patch-Clamp Techniques; Pyramidal Cells; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Triazoles; Zinc; Zolpidem | 1999 |
GABA(A) receptors expressed in undifferentiated human teratocarcinoma NT2 cells differ from those expressed by differentiated NT2-N cells.
Topics: Anti-Anxiety Agents; Anticonvulsants; Cell Differentiation; Diazepam; Furosemide; Humans; Lanthanum; Neurons; Patch-Clamp Techniques; Pyridines; Receptors, GABA-A; Teratocarcinoma; Triazoles; Tumor Cells, Cultured; Zinc; Zolpidem | 1999 |
Functional characterization of GABA(A) receptors in neonatal hypothalamic brain slice.
Topics: Anesthetics; Animals; Animals, Newborn; Anticonvulsants; Carbolines; Convulsants; Dehydroepiandrosterone Sulfate; Diazepam; Diuretics; Female; Furosemide; GABA Agonists; GABA Modulators; gamma-Aminobutyric Acid; Hypothalamus; Male; Membrane Potentials; Organ Culture Techniques; Patch-Clamp Techniques; Picrotoxin; Pregnanolone; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Triazoles; Zinc; Zolpidem | 2002 |
Major differences in inhibitory synaptic transmission onto two neocortical interneuron subclasses.
Topics: Action Potentials; Animals; GABA Agonists; gamma-Aminobutyric Acid; Gene Targeting; In Vitro Techniques; Interneurons; Mice; Mice, Mutant Strains; Neocortex; Neural Inhibition; Patch-Clamp Techniques; Protein Subunits; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Somatosensory Cortex; Synaptic Transmission; Triazoles; Zolpidem | 2003 |
Critically timed ethanol exposure reduces GABAAR function on septal neurons developing in vivo but not in vitro.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Bicuculline; Body Weight; Cells, Cultured; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Embryo, Mammalian; Ethanol; Female; GABA Agonists; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Membrane Potentials; Neurons; Patch-Clamp Techniques; Penicillins; Picrotoxin; Pregnancy; Protein Synthesis Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Septum of Brain; Streptomycin; Time Factors; Triazoles; Up-Regulation; Zinc; Zolpidem | 2004 |
Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis.
Topics: Adrenocorticotropic Hormone; Animals; Azabicyclo Compounds; Carbolines; Corticosterone; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Fluorobenzenes; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred Strains; Models, Biological; Paraventricular Hypothalamic Nucleus; Piperazines; Pituitary-Adrenal System; Proto-Oncogene Proteins c-fos; Pyridines; Radioimmunoassay; Receptors, GABA-A; Triazoles; Zolpidem | 2005 |
A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzodiazepinones; Chlordiazepoxide; Conflict, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drinking Behavior; Drug Interactions; Electroshock; Fluorobenzenes; GABA Agents; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Pyridines; Reaction Time; Reproducibility of Results; Time Factors; Triazoles; Water Deprivation; Zolpidem | 2005 |
High-affinity, slowly desensitizing GABAA receptors mediate tonic inhibition in hippocampal dentate granule cells.
Topics: Animals; Anticonvulsants; Dentate Gyrus; Diazepam; Diuretics; Furosemide; GABA Agonists; GABA Antagonists; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Hippocampus; Male; Neural Inhibition; Penicillins; Pyridines; Rats; Rats, Sprague-Dawley; Triazoles; Zolpidem | 2006 |
Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination.
Topics: Animals; Azabicyclo Compounds; Benzodiazepines; Benzodiazepinones; Chlordiazepoxide; Cues; Discrimination Learning; Fluorobenzenes; GABA Modulators; Generalization, Psychological; Male; Piperazines; Protein Subunits; Pyridazines; Pyridines; Rats; Receptors, GABA-A; Triazoles; Zolpidem | 2006 |
Effects of genetic background and null mutation of 5-HT1A receptors on basal and stress-induced body temperature: modulation by serotonergic and GABAA-ergic drugs.
Topics: Animals; Body Temperature; Body Temperature Regulation; Buspirone; Diazepam; Fever; Flumazenil; Fluorobenzenes; GABA Agonists; GABA Modulators; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyridines; Receptor, Serotonin, 5-HT1A; Receptors, GABA-A; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Stress, Psychological; Triazoles; Zolpidem | 2006 |
Pharmacological and computational analysis of alpha-subunit preferential GABA(A) positive allosteric modulators on the rat septo-hippocampal activity.
Topics: Action Potentials; Animals; Electroencephalography; Fluorobenzenes; GABA Agonists; GABA Antagonists; Hippocampus; Male; Models, Neurological; Neural Networks, Computer; Neural Pathways; Neurons; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Septum of Brain; Triazoles; Zolpidem | 2007 |
Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice.
Topics: Animals; Anxiety; Behavior, Animal; Chlordiazepoxide; Conflict, Psychological; Darkness; Fluorobenzenes; GABA Modulators; Hypnotics and Sedatives; Light; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Models, Psychological; Pyridines; Species Specificity; Triazoles; Zolpidem | 2008 |
Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.
Topics: Animals; Ataxia; Conditioning, Operant; Data Interpretation, Statistical; Discrimination, Psychological; Dose-Response Relationship, Drug; GABA Agonists; GABA Modulators; Generalization, Psychological; Hypnotics and Sedatives; Lorazepam; Male; Psychomotor Performance; Pyridazines; Pyridines; Rats; Rats, Long-Evans; Receptors, GABA-A; Triazoles; Zolpidem | 2008 |
GABA regulates the rat hypothalamic-pituitary-adrenocortical axis via different GABA-A receptor alpha-subtypes.
Topics: Animals; Brain; Corticotropin-Releasing Hormone; Diazepam; Fluorobenzenes; GABA Agonists; GABA Modulators; gamma-Aminobutyric Acid; Hypothalamo-Hypophyseal System; Male; Neural Pathways; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Protein Subunits; Proto-Oncogene Proteins c-fos; Pyridines; Random Allocation; Rats; Rats, Wistar; Receptors, GABA-A; Triazoles; Zolpidem | 2008 |
In vivo saturation binding of GABA-A receptor ligands to estimate receptor occupancy using liquid chromatography/tandem mass spectrometry.
Topics: Algorithms; Animals; Azabicyclo Compounds; Binding Sites; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Flumazenil; Fluorobenzenes; GABA Agonists; GABA Modulators; Hypnotics and Sedatives; In Vitro Techniques; Indicators and Reagents; Ligands; Male; Mice; Models, Statistical; Piperazines; Pyridines; Receptors, GABA-A; Stereoisomerism; Tandem Mass Spectrometry; Triazoles; Zolpidem | 2009 |
Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes.
Topics: Animals; Barbiturates; Carbolines; Catheterization; Central Nervous System Depressants; Diazepam; Discrimination, Psychological; Dose-Response Relationship, Drug; Ethanol; Flumazenil; Fluorobenzenes; GABA Agonists; GABA Antagonists; GABA Modulators; Neuropsychological Tests; Pyridines; Receptors, GABA-A; Saimiri; Triazoles; Zolpidem | 2010 |
Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem.
Topics: Allosteric Regulation; Animals; Anti-Anxiety Agents; Behavior, Animal; Chlordiazepoxide; Conditioning, Psychological; Hypnotics and Sedatives; Ligands; Male; Pyridazines; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Substrate Specificity; Triazoles; Zolpidem | 2011 |
GABA(A) receptor α subunits differentially contribute to diazepam tolerance after chronic treatment.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Benzodiazepinones; Body Temperature; Brain; Diazepam; DNA Primers; Drug Tolerance; Flumazenil; Hypnotics and Sedatives; In Situ Hybridization; Male; Mice; Mice, Mutant Strains; Pyridazines; Pyridines; Receptors, GABA-A; Triazoles; Zolpidem | 2012 |
Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition.
Topics: Administration, Oral; Animals; Attention; Azabicyclo Compounds; Choice Behavior; Cognition; Cytoskeletal Proteins; Diazepam; Eszopiclone; gamma-Aminobutyric Acid; Hippocampus; Hypnotics and Sedatives; Macaca mulatta; Male; Memory, Short-Term; Nerve Tissue Proteins; Orexin Receptors; Piperazines; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Recognition, Psychology; Sleep; Task Performance and Analysis; Time Factors; Triazoles; Zolpidem | 2013 |
Allosteric modulation of GABA(A) receptor subtypes:effects on visual recognition and visuospatial working memory in rhesus monkeys [corrected].
Topics: Acetamides; Allosteric Regulation; Animals; Benzodiazepines; Conditioning, Operant; Diazepam; Dose-Response Relationship, Drug; Imidazoles; Macaca mulatta; Male; Memory, Short-Term; Pyridazines; Pyridines; Pyrimidines; Receptors, GABA-A; Recognition, Psychology; Triazolam; Triazoles; Zolpidem | 2013 |
Quantitative electroencephalography within sleep/wake states differentiates GABAA modulators eszopiclone and zolpidem from dual orexin receptor antagonists in rats.
Topics: Animals; Azabicyclo Compounds; Brain; Electroencephalography; Eszopiclone; GABA-A Receptor Agonists; Male; Orexin Receptor Antagonists; Piperazines; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Sleep Stages; Triazoles; Zolpidem | 2013 |
Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autism.
Topics: Animals; Autistic Disorder; Behavior, Animal; Benzodiazepines; Brain; Disease Models, Animal; Fluorobenzenes; Interpersonal Relations; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Protein Subunits; Pyridines; Receptors, GABA-A; Social Behavior; Synaptic Transmission; Triazoles; Zolpidem | 2014 |
Pharmacodynamic effects of suvorexant and zolpidem on EEG during sleep in healthy subjects.
Topics: Adult; Aged; Azepines; Cross-Over Studies; Double-Blind Method; Electroencephalography; Healthy Volunteers; Humans; Hypnotics and Sedatives; Male; Middle Aged; Orexin Receptor Antagonists; Polysomnography; Pyridines; Sleep; Triazoles; Zolpidem | 2016 |
Benefits of switching to suvorexant for mild primary insomnia when sleepwalking episodes occur during zolpidem treatment.
Topics: Adult; Azepines; Female; GABA-A Receptor Agonists; Humans; Orexin Receptor Antagonists; Sleep Initiation and Maintenance Disorders; Somnambulism; Treatment Outcome; Triazoles; Zolpidem | 2017 |
Cost-effectiveness analysis of suvorexant for the treatment of Japanese elderly patients with chronic insomnia in a virtual cohort.
Topics: Aged; Aged, 80 and over; Azepines; Chronic Disease; Computer Simulation; Cost-Benefit Analysis; Female; Hip Fractures; Humans; Hypnotics and Sedatives; Japan; Male; Models, Econometric; Pyridines; Quality-Adjusted Life Years; Sleep Initiation and Maintenance Disorders; Triazoles; Zolpidem | 2018 |
Nail pitting and splinter hemorrhage possibly induced by zolpidem.
Topics: Adult; Drug Substitution; Female; Hemorrhage; Humans; Nail Diseases; Nails; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Triazoles; Young Adult; Zolpidem | 2019 |
Differential sleep/wake response and sex differences following acute suvorexant, MK-1064 and zolpidem administration in the rTg4510 mouse model of tauopathy.
Topics: Animals; Azepines; Disease Models, Animal; Female; Hypnotics and Sedatives; Male; Mice; Mice, Transgenic; Sex Characteristics; Sleep; Sleep Wake Disorders; Tauopathies; Triazoles; Zolpidem | 2022 |